Trials with Napabucasin
Every colorectal cancer trial that includes this drug. Those looking for patients come first.
Showing 1–2 of 2
NCT02851004
the efficacy and safety of BBI608 in combination with pembrolizumab
NCT02753127
This is an international multi-center, prospective, open-label, randomized, adaptive design phase 3 trial of the cancer stem cell pathway inhibitor napabucasin plus standard bi-weekly FOLFIRI versus standard bi-weekly FOLFIRI in patients w…